Evaluation of eSie VVI Technology on Left Ventricular Systolic Function Changes in Uremic Patients Undergoing Dialysis
- 54 Downloads
To analyze the longitudinal peak systolic strain of left ventricular myocardium in three layers before and after hemodialysis in uremic patients, and to explore the value of eSie VVI (Velocity Vector Imaging) technology in evaluating the changes of left ventricular myocardial systolic function in uremic patients in a short time after hemodialysis, the longitudinal peak systolic laminar strain and global full-thickness strain of 17 segments of the left ventricle are obtained by eSie VVI software analysis, and the results are deduced in Excel form. Statistical analysis is made on the results of longitudinal peak systolic stratified strain of left ventricular inner, middle and outer layers and whole myocardium in uremic patients before and after hemodialysis. The results show that eSie VVI technology can more sensitively and accurately evaluate the changes of left ventricular myocardial systolic function after hemodialysis in uremic patients, and has certain clinical value.
KeywordsEchocardiography VVI Uremia Hemodialysis
Compliance with ethical standards
Conflict of interest
Author Yafen Wang declares that he has no conflict of interest. Author Yiming Zhang declares that he has no conflict of interest. Author Weidong Liang declares that he has no conflict of interest. Author Liangdong Yuan declares that he has no conflict of interest. Author Shiqi Zhang declares that he has no conflict of interest. Author Yang Li declares that he has no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
This article does not contain any studies with animals performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 6.Chauveau, S., Anyukhovsky, E. P., Ben-Ari, M., Naor, S., Jiang, Y. P., Danilo, P. Jr, Rahim, T., Burke, S., Qiu, X., Potapova, I. A., Doronin, S. V., Brink, P. R., Binah, O., Cohen, I, S., and Rosen, M. R., Induced pluripotent stem cell-derived cardiomyocytes provide in vivo biological pacemaker function. Circ. Arrhythm. Electrophysiol. 10(5):e004508, 2017.Google Scholar
- 9.Li, Y., and Yuan, J., Evaluation of the effect of hemodialysis on left ventricular longitudinal strain function of myocardium in patients with uremia by velocity vector imaging. Ultrasound Med. Biol. 43:S76, 2017.Google Scholar
- 10.Claramunt, D., Gil-Peña, H., Fuente, R., García-López, E., Loredo, V., Hernández-Frías, O., Ordoñez, F. A., Rodríguez-Suárez, J., and Santos, F., Chronic kidney disease induced by adenine: A suitable model of growth retardation in uremia. Am. J. Physiol. Cell Physiol. 309(1):F57–F62, 2015.CrossRefGoogle Scholar
- 11.Katsube, Y., Tsujimoto, M., Koide, H., Ochiai, M., Hojyo, A., Ogawa, K., Kambara, K., Torii, N., Shima, D., Furukubo, T., Izumi, S., Yamakawa, T., Minegaki, T., and Nishiguchi, K., Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38. Cancer Chemother. Pharmacol. 79(4):783–789, 2017.CrossRefGoogle Scholar